Cigna Investments’s Huntington Bancshares HBAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $336K | Hold |
18,961
| – | – | 0.04% | 336 |
|
|
2026
Q1 | $297K | Buy |
18,961
+4,019
| +27% | +$68.7K | 0.05% | 339 |
|
|
2025
Q4 | $260K | Buy |
14,942
+1,066
| +8% | +$17.5K | 0.04% | 383 |
|
|
2025
Q3 | $239K | Sell |
13,876
-924
| -6% | -$15.8K | 0.03% | 407 |
|
|
2025
Q2 | $248K | Sell |
14,800
-322
| -2% | -$4.86K | 0.04% | 383 |
|
|
2025
Q1 | $227K | Hold |
15,122
| – | – | 0.04% | 401 |
|
|
2024
Q4 | $246K | Sell |
15,122
-306
| -2% | -$5.03K | 0.04% | 388 |
|
|
2024
Q3 | $226K | Hold |
15,428
| – | – | 0.04% | 414 |
|
|
2024
Q2 | $203K | Hold |
15,428
| – | – | 0.04% | 428 |
|
|
2024
Q1 | $215K | Hold |
15,428
| – | – | 0.04% | 422 |
|
|
2023
Q4 | $196K | Hold |
15,428
| – | – | 0.04% | 428 |
|
|
2023
Q3 | $161K | Sell |
15,428
-1,956
| -11% | -$21.9K | 0.04% | 406 |
|
|
2023
Q2 | $188K | Hold |
17,384
| – | – | 0.03% | 442 |
|
|
2023
Q1 | $195K | Sell |
17,384
-484
| -3% | -$6.74K | 0.04% | 438 |
|
|
2022
Q4 | $253K | Hold |
17,868
| – | – | 0.05% | 373 |
|
|
2022
Q3 | $236K | Sell |
17,868
-874
| -5% | -$11.7K | 0.05% | 376 |
|
|
2022
Q2 | $225K | Sell |
18,742
-6,626
| -26% | -$87.9K | 0.04% | 407 |
|
|
2022
Q1 | $371K | Sell |
25,368
-7,634
| -23% | -$120K | 0.05% | 382 |
|
|
2021
Q4 | $508K | Sell |
33,002
-12,528
| -28% | -$197K | 0.04% | 365 |
|
|
2021
Q3 | $704K | Sell |
45,530
-380
| -0.8% | -$5.59K | 0.05% | 324 |
|
|
2021
Q2 | $656K | Buy |
45,910
+9,238
| +25% | +$141K | 0.05% | 355 |
|
|
2021
Q1 | $576K | Buy |
36,672
+1,002
| +3% | +$15K | 0.04% | 407 |
|
|
2020
Q4 | $451K | Buy |
35,670
+2,449
| +7% | +$27.8K | 0.03% | 439 |
|
|
2020
Q3 | $305K | Buy |
33,221
+1,300
| +4% | +$12.1K | 0.03% | 477 |
|
|
2020
Q2 | $288K | Buy |
31,921
+2,600
| +9% | +$23K | 0.03% | 558 |
|
|
2020
Q1 | $241K | Buy |
29,321
+1,800
| +7% | +$22.1K | 0.03% | 509 |
|
|
2019
Q4 | $373K | Sell |
27,521
-2,559
| -9% | -$37.5K | 0.04% | 457 |
|
|
2019
Q3 | $426K | Sell |
30,080
-9,606
| -24% | -$131K | 0.04% | 434 |
|
|
2019
Q2 | $565K | Buy |
39,686
+9,906
| +33% | +$133K | 0.06% | 360 |
|
|
2019
Q1 | $378K | Sell |
29,780
-1,650
| -5% | -$22.2K | 0.04% | 456 |
|
|
2018
Q4 | $374K | Sell |
31,430
-802
| -2% | -$11.1K | 0.03% | 430 |
|
|
2018
Q3 | $462K | Sell |
32,232
-2,500
| -7% | -$39.1K | 0.04% | 386 |
|
|
2018
Q2 | $512K | Sell |
34,732
-4,100
| -11% | -$61.7K | 0.04% | 413 |
|
|
2018
Q1 | $587K | Sell |
38,832
-573
| -1% | -$9.01K | 0.04% | 392 |
|
|
2017
Q4 | $575K | Sell |
39,405
-1,400
| -3% | -$19.7K | 0.04% | 417 |
|
|
2017
Q3 | $569K | Sell |
40,805
-1,072
| -3% | -$14.1K | 0.04% | 407 |
|
|
2017
Q2 | $570K | Sell |
41,877
-3,118
| -7% | -$40.4K | 0.04% | 401 |
|
|
2017
Q1 | $606K | Buy |
44,995
+5,406
| +14% | +$73.9K | 0.04% | 387 |
|
|
2016
Q4 | $523K | Buy |
+39,589
| New | +$461K | 0.06% | 386 |
|
Other funds holding HBAN
LMFP
FWIA
VNIM
SFA
NCM
FVWA
CF
Cigna Investments's HBAN Position: Q2 2026 in Review
Cigna Investments held its Huntington Bancshares (HBAN) position steady in Q2 2026 at 18,961 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #336.
Cigna Investments first reported a position in HBAN in Q4 2016 and has held it in 39 quarters since. The position peaked at $704K in Q3 2021. 241 funds tracked by Wall St. Rank hold HBAN as of Q2 2026.
- Cigna Investments held 18,961 shares of Huntington Bancshares worth $336K as of Q2 2026.
- Cigna Investments left its Huntington Bancshares share count unchanged in Q2 2026.
- Huntington Bancshares made up 0.04% of Cigna Investments's portfolio in Q2 2026, its #336 holding.
- Cigna Investments first reported a position in Huntington Bancshares in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Huntington Bancshares position peaked at $704K in Q3 2021.
- 241 funds tracked by Wall St. Rank held Huntington Bancshares as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.